Efficacy of Low-Dose Continuous Infusion of Human Atrial Natriuretic Peptide (hANP) During Lung Resection Surgery
Phase 2
- Conditions
- ung Resection Surgery
- Registration Number
- JPRN-UMIN000001524
- Lead Sponsor
- Toneyama National Hospital
- Brief Summary
Continuous infusion of low-dose human atrial natriuretic peptide during lung cancer surgery had a prophylactic effect against postoperative atrial fibrillation after pulmonary resection in patients with preoperative elevation of B-type natriuretic peptide levels.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method whether infusion of hANP during pulmonary resection has an effect on the reduction of postoperative complications (atrial fibrillation)
- Secondary Outcome Measures
Name Time Method Postoperative hemodynamics, white blood cell counts, and C-reactive protein levels